IP Library › Granted Patent US 9,987,222
Granted Patent B2
US 9,987,222 · App. 14/372,600 · Granted Jun 5, 2018

Method for administration of a probiotic

Inventor: Floris Koumans (Delft, NL)
Assignee: BIOSOMA B.V.
A61K9/0034A61K35/741A61K35/747A61M31/007A61K9/06A61K9/4841
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,987,222
App. No.
14/372,600
Granted
Jun 5, 2018
Kind
B2
Abstract

The present invention relates to a method for the administration of a probiotic composition to a vaginal cavity and to compositions, devices and kits for use in this method.

Claims (11)

1. A method for vaginal administration of a probiotic composition using an applicator, the applicator comprising a tube having a proximal and a distal end, the proximal end configured for introduction into a vaginal cavity during use, the tube adapted for expelling both a prebiotic composition and the probiotic composition from the proximal end; the method comprising the steps of:

transferring a prebiotic composition, in liquid form, to the applicator from a container separate from the applicator before placing a probiotic composition in the proximal end of the tube, wherein the container separate from the applicator is detachably attached to the proximal end of the tube;

placing the probiotic composition in encapsulated dry form in the proximal end of the tube of the applicator;

introducing the proximal end of the tube into a vaginal cavity;

forcing the prebiotic composition out of the proximal end of the tube, the prebiotic composition expelling the probiotic composition from the proximal end of the tube and into the vaginal cavity, the prebiotic composition interacting with, and activating, probiotics in the probiotic composition; and

contacting mucosal or endometrial surfaces of the vagina with the activated probiotics, therein promoting probiotic growth and colonization in the vaginal cavity.

2. The method of claim 1 , wherein the prebiotic composition has a viscosity of between 0.5 and 40 Pa·s measured at 19-21 degrees Celsius and at a spindle 4-7 at 12 rpm or spindle 4-7 at 20 rpm using a Viscometer & Model Brookfield DV-II+ Programmable.

3. The method of claim 1 , wherein the prebiotic composition comprises an anti-fungal composition.

4. The method of claim 1 , further comprising the step of placing the proximal end of the tube near the vaginal fornices before forcing the prebiotic composition out of the proximal end of the tube.

5. The method of claim 1 , wherein the container separate from the applicator is detached from the applicator before the tube is introduced into the vaginal cavity.

6. The method of claim 1 , wherein the prebiotic composition interacts with and activates the probiotics in the probiotic composition once in the vaginal cavity.

Assignments (2)
NUNC PRO TUNC ASSIGNMENT Recorded Oct 10, 2017
From: KOUMANS, FLORIS JAN ROBERT
To: BIOCLIN B.V.
Reel/Frame 043825/0829 →
NUNC PRO TUNC ASSIGNMENT Recorded Oct 10, 2017
From: BIOCLIN B.V.
To: BIOSOMA B.V.
Reel/Frame 043825/0930 →
Priority Claims (1)
EP 12153401 · Jan 31, 2012 · regional
Continuity (1)
Related Publication 20140358092A1 · Dec 4, 2014